Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare announces plan to negotiate prices of diabetes, weight loss drugs
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.
USA TODAY on MSN13d
Medicare caps seniors drug expenses: What you need to knowThe cap will reduce out-of-pocket spending for potentially millions of older Americans in Medicare Part D, which covers ...
U.S. Senator Jacky Rosen announced that 15 additional medications have been selected for Medicare drug pricing negotiations, ...
Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being ...
Medicare Payment Advisory Commission recommends tying physician payment update to care cost growth; AMA calls for Congress to act on analysis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback